INTRODUCTION “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021,” Pfizer’s post-marketing report, a required U.S. Food and Drug Administration (FDA) compliance document, is one of the ways in which the FDA assessed patients’ risks associated with Pfizer’s COVID-19 vaccine, BNT162b2. The data within the Pfizer’s 5.3.6 analysis are not […]
Report 68: 34 Blood Vessel Inflammation, Vasculitis, Adverse Events Occurred in First 90 Days After Pfizer mRNA “Vaccine” Rollout, Including One Fatality. Half Had Onset Within Three Days of Injection. 81% of Sufferers Were Women.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote an important review of vasculitis adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). The search criterion […]
Report 58: Histopathology Series Part 2 – “Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus”
This report is a follow-up to “Report 56: Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus” and offers critical additional analysis. Histopathological reevaluation of serious adverse events and deaths following COVID-19 vaccination Professor Arne Burkhardt Pathologist Reutlingen, Germany Professor Dr. Arne Burkhardt gave an update on his series of […]